Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics

Cell Metabolism

Volumn 25, Issue 2, 2017, Pages 262-284

  Puchalska, Patrycja ^a   Crawford, Peter A ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

alternative fuel; cancer metabolism; carbohydrate restriction; cardiac metabolism; extrahepatic ketogenesis; fuel metabolism; HMGCS2; ketogenic diet; mitochondrial function; NAFLD; SCOT

Indexed keywords

CARBOHYDRATE; KETONE BODY;

CELL METABOLISM; FATTY ACID METABOLISM; HEART FAILURE; HUMAN; KETOGENESIS; KETOGENIC DIET; LIVER CELL; MALIGNANT NEOPLASM; NEUROPROTECTION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ENERGY METABOLISM; METABOLISM; NEOPLASM;

ANIMALS; ENERGY METABOLISM; HEPATOCYTES; HUMANS; KETONE BODIES; NEOPLASMS; NEUROPROTECTION; SIGNAL TRANSDUCTION;

EID: 85013177882     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2016.12.022     Document Type: Review

References (372)

1. Abdelmegeed, M.A., Kim, S.K., Woodcroft, K.J., Novak, R.F., Acetoacetate activation of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in primary cultured rat hepatocytes: role of oxidative stress. J. Pharmacol. Exp. Ther. 310 (2004), 728–736.
2. Adijanto, J., Du, J., Moffat, C., Seifert, E.L., Hurle, J.B., Philp, N.J., The retinal pigment epithelium utilizes fatty acids for ketogenesis. J. Biol. Chem. 289 (2014), 20570–20582.
3. Aguiló, F., Camarero, N., Relat, J., Marrero, P.F., Haro, D., Transcriptional regulation of the human acetoacetyl-CoA synthetase gene by PPARgamma. Biochem. J. 427 (2010), 255–264.
4. Ahmed, K., Tunaru, S., Offermanns, S., GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors. Trends Pharmacol. Sci. 30 (2009), 557–562.
5. Al-Zaid, N.S., Dashti, H.M., Mathew, T.C., Juggi, J.S., Low carbohydrate ketogenic diet enhances cardiac tolerance to global ischaemia. Acta Cardiol. 62 (2007), 381–389.
6. Aneja, P., Dziak, R., Cai, G.Q., Charles, T.C., Identification of an acetoacetyl coenzyme A synthetase-dependent pathway for utilization of L-(+)-3-hydroxybutyrate in Sinorhizobium meliloti. J. Bacteriol. 184 (2002), 1571–1577.
7. Arias, G., Matas, R., Asins, G., Hegardt, F.G., Serra, D., The effect of fasting and insulin treatment on carnitine palmitoyl transferase I and mitochondrial 3-hydroxy-3-methylglutaryl coenzyme A synthase mRNA levels in liver from suckling rats. Biochem. Soc. Trans., 23, 1995, 493S.
8. Ashrafian, H., Frenneaux, M.P., Opie, L.H., Metabolic mechanisms in heart failure. Circulation 116 (2007), 434–448.
9. Aubert, G., Martin, O.J., Horton, J.L., Lai, L., Vega, R.B., Leone, T.C., Koves, T., Gardell, S.J., Krüger, M., Hoppel, C.L., et al. The failing heart relies on ketone bodies as a fuel. Circulation 133 (2016), 698–705.
10. Avogaro, A., Doria, A., Gnudi, L., Carraro, A., Duner, E., Brocco, E., Tiengo, A., Crepaldi, G., Bier, D.M., Nosadini, R., Forearm ketone body metabolism in normal and in insulin-dependent diabetic patients. Am. J. Physiol. 263 (1992), E261–E267.
11. Ayté, J., Gil-Gómez, G., Hegardt, F.G., Methylation of the regulatory region of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene leads to its transcriptional inactivation. Biochem. J. 295 (1993), 807–812.
12. Badman, M.K., Pissios, P., Kennedy, A.R., Koukos, G., Flier, J.S., Maratos-Flier, E., Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5 (2007), 426–437.
13. Bae, H.R., Kim, D.H., Park, M.H., Lee, B., Kim, M.J., Lee, E.K., Chung, K.W., Kim, S.M., Im, D.S., Chung, H.Y., β-Hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via AMPK activation. Oncotarget 7 (2016), 66444–66454.
14. Bailey, J.W., Haymond, M.W., Miles, J.M., Validation of two-pool model for in vivo ketone body kinetics. Am. J. Physiol. 258 (1990), E850–E855.
15. Balasse, E.O., Féry, F., Ketone body production and disposal: effects of fasting, diabetes, and exercise. Diabetes Metab. Rev. 5 (1989), 247–270.
16. Balasse, E.O., Fery, F., Neef, M.A., Changes induced by exercise in rates of turnover and oxidation of ketone bodies in fasting man. J. Appl. Physiol. 44 (1978), 5–11.
17. Bedi, K.C. Jr., Snyder, N.W., Brandimarto, J., Aziz, M., Mesaros, C., Worth, A.J., Wang, L.L., Javaheri, A., Blair, I.A., Margulies, K.B., Rame, J.E., Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure. Circulation 133 (2016), 706–716.
18. Bentourkia, M., Tremblay, S., Pifferi, F., Rousseau, J., Lecomte, R., Cunnane, S., PET study of 11C-acetoacetate kinetics in rat brain during dietary treatments affecting ketosis. Am. J. Physiol. Endocrinol. Metab. 296 (2009), E796–E801.
19. Benyó, Z., Gille, A., Kero, J., Csiky, M., Suchánková, M.C., Nüsing, R.M., Moers, A., Pfeffer, K., Offermanns, S., GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J. Clin. Invest. 115 (2005), 3634–3640.
20. Benyó, Z., Gille, A., Bennett, C.L., Clausen, B.E., Offermanns, S., Nicotinic acid-induced flushing is mediated by activation of epidermal Langerhans cells. Mol. Pharmacol. 70 (2006), 1844–1849.
21. Bergman, B.C., Cornier, M.A., Horton, T.J., Bessesen, D.H., Effects of fasting on insulin action and glucose kinetics in lean and obese men and women. Am. J. Physiol. Endocrinol. Metab. 293 (2007), E1103–E1111.
22. Bergstrom, J.D., Wong, G.A., Edwards, P.A., Edmond, J., The regulation of acetoacetyl-CoA synthetase activity by modulators of cholesterol synthesis in vivo and the utilization of acetoacetate for cholesterogenesis. J. Biol. Chem. 259 (1984), 14548–14553.
23. Berry, G.T., Fukao, T., Mitchell, G.A., Mazur, A., Ciafre, M., Gibson, J., Kondo, N., Palmieri, M.J., Neonatal hypoglycaemia in severe succinyl-CoA: 3-oxoacid CoA-transferase deficiency. J. Inherit. Metab. Dis. 24 (2001), 587–595.
24. Bickerton, A.S., Roberts, R., Fielding, B.A., Tornqvist, H., Blaak, E.E., Wagenmakers, A.J., Gilbert, M., Humphreys, S.M., Karpe, F., Frayn, K.N., Adipose tissue fatty acid metabolism in insulin-resistant men. Diabetologia 51 (2008), 1466–1474.
25. Bing, R.J., The metabolism of the heart. Harvey Lect. 50 (1954–1955), 27–70.
26. Bisschop, P.H., de Metz, J., Ackermans, M.T., Endert, E., Pijl, H., Kuipers, F., Meijer, A.J., Sauerwein, H.P., Romijn, J.A., Dietary fat content alters insulin-mediated glucose metabolism in healthy men. Am. J. Clin. Nutr. 73 (2001), 554–559.
27. Bock, H., Fleischer, S., Preparation of a homogeneous soluble D-beta-hydroxybutyrate apodehydrogenase from mitochondria. J. Biol. Chem. 250 (1975), 5774–5781.
28. Bonuccelli, G., Tsirigos, A., Whitaker-Menezes, D., Pavlides, S., Pestell, R.G., Chiavarina, B., Frank, P.G., Flomenberg, N., Howell, A., Martinez-Outschoorn, U.E., et al. Ketones and lactate “fuel” tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 9 (2010), 3506–3514.
29. Boukaftane, Y., Duncan, A., Wang, S., Labuda, D., Robert, M.F., Sarrazin, J., Schappert, K., Mitchell, G.A., Human mitochondrial HMG CoA synthase: liver cDNA and partial genomic cloning, chromosome mapping to 1p12-p13, and possible role in vertebrate evolution. Genomics 23 (1994), 552–559.
30. Brégère, C., Rebrin, I., Gallaher, T.K., Sohal, R.S., Effects of age and calorie restriction on tryptophan nitration, protein content, and activity of succinyl-CoA:3-ketoacid CoA transferase in rat kidney mitochondria. Free Radic. Biol. Med. 48 (2010), 609–618.
31. Browning, J.D., Baker, J.A., Rogers, T., Davis, J., Satapati, S., Burgess, S.C., Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am. J. Clin. Nutr. 93 (2011), 1048–1052.
32. Brunengraber, H., Potential of ketone body esters for parenteral and oral nutrition. Nutrition 13 (1997), 233–235.
33. Cahill, G.F. Jr., Fuel metabolism in starvation. Annu. Rev. Nutr. 26 (2006), 1–22.
34. Camarero, N., Mascaró, C., Mayordomo, C., Vilardell, F., Haro, D., Marrero, P.F., Ketogenic HMGCS2 is a c-Myc target gene expressed in differentiated cells of human colonic epithelium and down-regulated in colon cancer. Mol. Cancer Res. 4 (2006), 645–653.
35. Camberos-Luna, L., Gerónimo-Olvera, C., Montiel, T., Rincon-Heredia, R., Massieu, L., The ketone body, β-hydroxybutyrate stimulates the autophagic flux and prevents neuronal death induced by glucose deprivation in cortical cultured neurons. Neurochem. Res. 41 (2016), 600–609.
36. Carley, A.N., Taegtmeyer, H., Lewandowski, E.D., Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart. Circ. Res. 114 (2014), 717–729.
37. Carpenter, R.G., Grossman, S.P., Plasma fat metabolites and hunger. Physiol. Behav. 30 (1983), 57–63.
38. Chavan, R., Feillet, C., Costa, S.S., Delorme, J.E., Okabe, T., Ripperger, J.A., Albrecht, U., Liver-derived ketone bodies are necessary for food anticipation. Nat. Commun., 7, 2016, 10580.
39. Chen, S.W., Chou, C.T., Chang, C.C., Li, Y.J., Chen, S.T., Lin, I.C., Kok, S.H., Cheng, S.J., Lee, J.J., Wu, T.S., et al. HMGCS2 enhances invasion and metastasis via direct interaction with PPARα to activate Src signaling in colorectal cancer and oral cancer. Oncotarget, 2016, 10.18632/oncotarget.13006 Published online November 1, 2016.
40. Chen, Y., Zhao, W., Yang, J.S., Cheng, Z., Luo, H., Lu, Z., Tan, M., Gu, W., Zhao, Y., Quantitative acetylome analysis reveals the roles of SIRT1 in regulating diverse substrates and cellular pathways. Mol. Cell. Proteomics 11 (2012), 1048–1062.
41. Cherbuy, C., Darcy-Vrillon, B., Morel, M.T., Pégorier, J.P., Duée, P.H., Effect of germfree state on the capacities of isolated rat colonocytes to metabolize n-butyrate, glucose, and glutamine. Gastroenterology 109 (1995), 1890–1899.
42. Choudhary, C., Weinert, B.T., Nishida, Y., Verdin, E., Mann, M., The growing landscape of lysine acetylation links metabolism and cell signalling. Nat. Rev. Mol. Cell Biol. 15 (2014), 536–550.
43. Ciarlone, S.L., Grieco, J.C., D'Agostino, D.P., Weeber, E.J., Ketone ester supplementation attenuates seizure activity, and improves behavior and hippocampal synaptic plasticity in an Angelman syndrome mouse model. Neurobiol. Dis. 96 (2016), 38–46.
44. Clarke, K., Tchabanenko, K., Pawlosky, R., Carter, E., Todd King, M., Musa-Veloso, K., Ho, M., Roberts, A., Robertson, J., Vanitallie, T.B., Veech, R.L., Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul. Toxicol. Pharmacol. 63 (2012), 401–408.
45. Clarke, K., Tchabanenko, K., Pawlosky, R., Carter, E., Knight, N.S., Murray, A.J., Cochlin, L.E., King, M.T., Wong, A.W., Roberts, A., et al. Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate. Regul. Toxicol. Pharmacol. 63 (2012), 196–208.
46. Comerford, S.A., Huang, Z., Du, X., Wang, Y., Cai, L., Witkiewicz, A.K., Walters, H., Tantawy, M.N., Fu, A., Manning, H.C., et al. Acetate dependence of tumors. Cell 159 (2014), 1591–1602.
47. Cook, G.A., Lavrentyev, E.N., Pham, K., Park, E.A., Streptozotocin diabetes increases mRNA expression of ketogenic enzymes in the rat heart. Biochim. Biophys. Acta 1861 (2017), 307–312.
48. Cooper, R.H., Randle, P.J., Denton, R.M., Stimulation of phosphorylation and inactivation of pyruvate dehydrogenase by physiological inhibitors of the pyruvate dehydrogenase reaction. Nature 257 (1975), 808–809.
49. Corbet, C., Pinto, A., Martherus, R., Santiago de Jesus, J.P., Polet, F., Feron, O., Acidosis drives the reprogramming of fatty acid metabolism in cancer cells through changes in mitochondrial and histone acetylation. Cell Metab. 24 (2016), 311–323.
50. Cotter, D.G., d'Avignon, D.A., Wentz, A.E., Weber, M.L., Crawford, P.A., Obligate role for ketone body oxidation in neonatal metabolic homeostasis. J. Biol. Chem. 286 (2011), 6902–6910.
51. Cotter, D.G., Schugar, R.C., Crawford, P.A., Ketone body metabolism and cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 304 (2013), H1060–H1076.
52. Cotter, D.G., Schugar, R.C., Wentz, A.E., d'Avignon, D.A., Crawford, P.A., Successful adaptation to ketosis by mice with tissue-specific deficiency of ketone body oxidation. Am. J. Physiol. Endocrinol. Metab. 304 (2013), E363–E374.
53. Cotter, D.G., Ercal, B., Huang, X., Leid, J.M., d'Avignon, D.A., Graham, M.J., Dietzen, D.J., Brunt, E.M., Patti, G.J., Crawford, P.A., Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia. J. Clin. Invest. 124 (2014), 5175–5190.
54. Cox, P.J., Kirk, T., Ashmore, T., Willerton, K., Evans, R., Smith, A., Murray, A.J., Stubbs, B., West, J., McLure, S.W., et al. Nutritional ketosis alters fuel preference and thereby endurance performance in athletes. Cell Metab. 24 (2016), 256–268.
55. Crawford, P.A., Crowley, J.R., Sambandam, N., Muegge, B.D., Costello, E.K., Hamady, M., Knight, R., Gordon, J.I., Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation. Proc. Natl. Acad. Sci. USA 106 (2009), 11276–11281.
56. Cunnane, S.C., Crawford, M.A., Survival of the fattest: fat babies were the key to evolution of the large human brain. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 136 (2003), 17–26.
57. D'Agostino, D.P., Pilla, R., Held, H.E., Landon, C.S., Puchowicz, M., Brunengraber, H., Ari, C., Arnold, P., Dean, J.B., Therapeutic ketosis with ketone ester delays central nervous system oxygen toxicity seizures in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304 (2013), R829–R836.
58. Das, S., Morvan, F., Jourde, B., Meier, V., Kahle, P., Brebbia, P., Toussaint, G., Glass, D.J., Fornaro, M., ATP citrate lyase improves mitochondrial function in skeletal muscle. Cell Metab. 21 (2015), 868–876.
59. Davuluri, G., Song, P., Liu, Z., Wald, D., Sakaguchi, T.F., Green, M.R., Devireddy, L., Inactivation of 3-hydroxybutyrate dehydrogenase 2 delays zebrafish erythroid maturation by conferring premature mitophagy. Proc. Natl. Acad. Sci. USA 113 (2016), E1460–E1469.
60. De Feyter, H.M., Behar, K.L., Rao, J.U., Madden-Hennessey, K., Ip, K.L., Hyder, F., Drewes, L.R., Geschwind, J.F., de Graaf, R.A., Rothman, D.L., A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth. Neuro-oncol. 18 (2016), 1079–1087.
61. Degirolamo, C., Sabbà, C., Moschetta, A., Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. Nat. Rev. Drug Discov. 15 (2016), 51–69.
62. DeNicola, G.M., Cantley, L.C., Cancer's fuel choice: new flavors for a picky eater. Mol. Cell 60 (2015), 514–523.
63. Des Rosiers, C., Montgomery, J.A., Garneau, M., David, F., Mamer, O.A., Daloze, P., Toffolo, G., Cobelli, C., Landau, B.R., Brunengraber, H., Pseudoketogenesis in hepatectomized dogs. Am. J. Physiol. 258 (1990), E519–E528.
64. Desrochers, S., David, F., Garneau, M., Jetté, M., Brunengraber, H., Metabolism of R- and S-1,3-butanediol in perfused livers from meal-fed and starved rats. Biochem. J. 285 (1992), 647–653.
65. Desrochers, S., Dubreuil, P., Brunet, J., Jetté, M., David, F., Landau, B.R., Brunengraber, H., Metabolism of (R,S)-1,3-butanediol acetoacetate esters, potential parenteral and enteral nutrients in conscious pigs. Am. J. Physiol. 268 (1995), E660–E667.
66. Desrochers, S., Quinze, K., Dugas, H., Dubreuil, P., Bomont, C., David, F., Agarwal, K.C., Kumar, A., Soloviev, M.V., Powers, L., et al. R,S-1,3-butanediol acetoacetate esters, potential alternates to lipid emulsions for total parenteral nutrition. J. Nutr. Biochem. 6 (1995), 111–118.
67. Dittenhafer-Reed, K.E., Richards, A.L., Fan, J., Smallegan, M.J., Fotuhi Siahpirani, A., Kemmerer, Z.A., Prolla, T.A., Roy, S., Coon, J.J., Denu, J.M., SIRT3 mediates multi-tissue coupling for metabolic fuel switching. Cell Metab. 21 (2015), 637–646.
68. Douris, N., Melman, T., Pecherer, J.M., Pissios, P., Flier, J.S., Cantley, L.C., Locasale, J.W., Maratos-Flier, E., Adaptive changes in amino acid metabolism permit normal longevity in mice consuming a low-carbohydrate ketogenic diet. Biochim. Biophys. Acta 1852 (2015), 2056–2065.
69. Dutta, A., Abmayr, S.M., Workman, J.L., Diverse activities of histone acylations connect metabolism to chromatin function. Mol. Cell 63 (2016), 547–552.
70. Edmond, J., Ketone bodies as precursors of sterols and fatty acids in the developing rat. J. Biol. Chem. 249 (1974), 72–80.
71. Edmond, J., Robbins, R.A., Bergstrom, J.D., Cole, R.A., de Vellis, J., Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture. J. Neurosci. Res. 18 (1987), 551–561.
72. Ehara, T., Kamei, Y., Yuan, X., Takahashi, M., Kanai, S., Tamura, E., Tsujimoto, K., Tamiya, T., Nakagawa, Y., Shimano, H., et al. Ligand-activated PPARα-dependent DNA demethylation regulates the fatty acid β-oxidation genes in the postnatal liver. Diabetes 64 (2015), 775–784.
73. El Azzouny, M., Longacre, M.J., Ansari, I.U., Kennedy, R.T., Burant, C.F., MacDonald, M.J., Knockdown of ATP citrate lyase in pancreatic beta cells does not inhibit insulin secretion or glucose flux and implicates the acetoacetate pathway in insulin secretion. Mol. Metab. 5 (2016), 980–987.
74. 1H-NMR spectroscopy. PLoS ONE, 11, 2016, e0155094.
75. Endemann, G., Goetz, P.G., Edmond, J., Brunengraber, H., Lipogenesis from ketone bodies in the isolated perfused rat liver. Evidence for the cytosolic activation of acetoacetate. J. Biol. Chem. 257 (1982), 3434–3440.
76. Fabbrini, E., Magkos, F., Mohammed, B.S., Pietka, T., Abumrad, N.A., Patterson, B.W., Okunade, A., Klein, S., Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. USA 106 (2009), 15430–15435.
77. Fabbrini, E., Mohammed, B.S., Korenblat, K.M., Magkos, F., McCrea, J., Patterson, B.W., Klein, S., Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 95 (2010), 2727–2735.
78. Fabbrini, E., Sullivan, S., Klein, S., Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51 (2010), 679–689.
79. Fan, J., Krautkramer, K.A., Feldman, J.L., Denu, J.M., Metabolic regulation of histone post-translational modifications. ACS Chem. Biol. 10 (2015), 95–108.
80. Farese, R.V. Jr., Zechner, R., Newgard, C.B., Walther, T.C., The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. Cell Metab. 15 (2012), 570–573.
81. Felig, P., Wahren, J., Hendler, R., Brundin, T., Splanchnic glucose and amino acid metabolism in obesity. J. Clin. Invest. 53 (1974), 582–590.
82. Fenselau, A., Wallis, K., Substrate specificity and mechanism of action of acetoacetate coenzyme A transferase from rat heart. Biochemistry 13 (1974), 3884–3888.
83. Fenselau, A., Wallis, K., 3-oxo acid coenzyme A-transferase in normal and diabetic rat muscle. Biochem. J. 158 (1976), 509–512.
84. Ferrannini, E., Muscelli, E., Frascerra, S., Baldi, S., Mari, A., Heise, T., Broedl, U.C., Woerle, H.J., Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. J. Clin. Invest. 124 (2014), 499–508.
85. Ferrannini, E., Baldi, S., Frascerra, S., Astiarraga, B., Heise, T., Bizzotto, R., Mari, A., Pieber, T.R., Muscelli, E., Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes. Diabetes 65 (2016), 1190–1195.
86. Ferrannini, E., Mark, M., Mayoux, E., CV protection in the EMPA-REG OUTCOME trial: a “thrifty substrate” hypothesis. Diabetes Care 39 (2016), 1108–1114.
87. Ferré, P., Satabin, P., Decaux, J.F., Escriva, F., Girard, J., Development and regulation of ketogenesis in hepatocytes isolated from newborn rats. Biochem. J. 214 (1983), 937–942.
88. Fink, G., Desrochers, S., Des Rosiers, C., Garneau, M., David, F., Daloze, T., Landau, B.R., Brunengraber, H., Pseudoketogenesis in the perfused rat heart. J. Biol. Chem. 263 (1988), 18036–18042.
89. Fitchett, D., Zinman, B., Wanner, C., Lachin, J.M., Hantel, S., Salsali, A., Johansen, O.E., Woerle, H.J., Broedl, U.C., Inzucchi, S.E., EMPA-REG OUTCOME® trial investigators. Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial. Eur. Heart J. 37 (2016), 1526–1534.
90. Flint, T.R., Janowitz, T., Connell, C.M., Roberts, E.W., Denton, A.E., Coll, A.P., Jodrell, D.I., Fearon, D.T., Tumor-induced IL-6 reprograms host metabolism to suppress anti-tumor immunity. Cell Metab. 24 (2016), 672–684.
91. Foster, D.W., Studies in the ketosis of fasting. J. Clin. Invest. 46 (1967), 1283–1296.
92. Foster, G.D., Wyatt, H.R., Hill, J.O., Makris, A.P., Rosenbaum, D.L., Brill, C., Stein, R.I., Mohammed, B.S., Miller, B., Rader, D.J., et al. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Ann. Intern. Med. 153 (2010), 147–157.
93. Freed, L.E., Endemann, G., Tomera, J.F., Gavino, V.C., Brunengraber, H., Lipogenesis from ketone bodies in perfused livers from streptozocin-induced diabetic rats. Diabetes 37 (1988), 50–55.
94. Frey, S., Geffroy, G., Desquiret-Dumas, V., Gueguen, N., Bris, C., Belal, S., Amati-Bonneau, P., Chevrollier, A., Barth, M., Henrion, D., et al. The addition of ketone bodies alleviates mitochondrial dysfunction by restoring complex I assembly in a MELAS cellular model. Biochim. Biophys. Acta 1863 (2017), 284–291.
95. Fu, S.P., Li, S.N., Wang, J.F., Li, Y., Xie, S.S., Xue, W.J., Liu, H.M., Huang, B.X., Lv, Q.K., Lei, L.C., et al. BHBA suppresses LPS-induced inflammation in BV-2 cells by inhibiting NF-κB activation. Mediators Inflamm., 2014, 2014, 983401.
96. Fu, S.P., Liu, B.R., Wang, J.F., Xue, W.J., Liu, H.M., Zeng, Y.L., Huang, B.X., Li, S.N., Lv, Q.K., Wang, W., Liu, J.X., β-Hydroxybutyric acid inhibits growth hormone-releasing hormone synthesis and secretion through the GPR109A/extracellular signal-regulated 1/2 signalling pathway in the hypothalamus. J. Neuroendocrinol. 27 (2015), 212–222.
97. Fukao, T., Mitchell, G.A., Song, X.Q., Nakamura, H., Kassovska-Bratinova, S., Orii, K.E., Wraith, J.E., Besley, G., Wanders, R.J.A., Niezen-Koning, K.E., et al. Succinyl-CoA:3-ketoacid CoA transferase (SCOT): cloning of the human SCOT gene, tertiary structural modeling of the human SCOT monomer, and characterization of three pathogenic mutations. Genomics 68 (2000), 144–151.
98. Fukao, T., Lopaschuk, G.D., Mitchell, G.A., Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot. Essent. Fatty Acids 70 (2004), 243–251.
99. Gambhir, D., Ananth, S., Veeranan-Karmegam, R., Elangovan, S., Hester, S., Jennings, E., Offermanns, S., Nussbaum, J.J., Smith, S.B., Thangaraju, M., et al. GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 53 (2012), 2208–2217.
100. Garbow, J.R., Doherty, J.M., Schugar, R.C., Travers, S., Weber, M.L., Wentz, A.E., Ezenwajiaku, N., Cotter, D.G., Brunt, E.M., Crawford, P.A., Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet. Am. J. Physiol. Gastrointest. Liver Physiol. 300 (2011), G956–G967.
101. Garland, P.B., Newsholme, E.A., Randle, P.J., Effect of fatty acids, ketone bodies, diabetes and starvation on pyruvate metabolism in rat heart and diaphragm muscle. Nature 195 (1962), 381–383.
102. Geelen, M.J., Lopes-Cardozo, M., Edmond, J., Acetoacetate: a major substrate for the synthesis of cholesterol and fatty acids by isolated rat hepatocytes. FEBS Lett. 163 (1983), 269–273.
103. Gibson, A.A., Seimon, R.V., Lee, C.M., Ayre, J., Franklin, J., Markovic, T.P., Caterson, I.D., Sainsbury, A., Do ketogenic diets really suppress appetite? A systematic review and meta-analysis. Obes. Rev. 16 (2015), 64–76.
104. Girard, J., Ferré, P., Pégorier, J.P., Duée, P.H., Adaptations of glucose and fatty acid metabolism during perinatal period and suckling-weaning transition. Physiol. Rev. 72 (1992), 507–562.
105. Goldman, D.S., Studies on the fatty acid oxidizing system of animal tissues. VII. The beta-ketoacyl coenzyme A cleavage enzyme. J. Biol. Chem. 208 (1954), 345–357.
106. Goldstein, L., Renal substrate utilization in normal and acidotic rats. Am. J. Physiol. 253 (1987), F351–F357.
107. Grabacka, M.M., Wilk, A., Antonczyk, A., Banks, P., Walczyk-Tytko, E., Dean, M., Pierzchalska, M., Reiss, K., Fenofibrate induces ketone body production in melanoma and glioblastoma cells. Front. Endocrinol. (Lausanne), 7, 2016, 5.
108. Graff, E.C., Fang, H., Wanders, D., Judd, R.L., Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2. Metabolism 65 (2016), 102–113.
109. Grimsrud, P.A., Carson, J.J., Hebert, A.S., Hubler, S.L., Niemi, N.M., Bailey, D.J., Jochem, A., Stapleton, D.S., Keller, M.P., Westphall, M.S., et al. A quantitative map of the liver mitochondrial phosphoproteome reveals posttranslational control of ketogenesis. Cell Metab. 16 (2012), 672–683.
110. Grinblat, L., Pacheco Bolaños, L.F., Stoppani, A.O., Decreased rate of ketone-body oxidation and decreased activity of D-3-hydroxybutyrate dehydrogenase and succinyl-CoA:3-oxo-acid CoA-transferase in heart mitochondria of diabetic rats. Biochem. J. 240 (1986), 49–56.
111. Guo, K., Lukacik, P., Papagrigoriou, E., Meier, M., Lee, W.H., Adamski, J., Oppermann, U., Characterization of human DHRS6, an orphan short chain dehydrogenase/reductase enzyme: a novel, cytosolic type 2 R-beta-hydroxybutyrate dehydrogenase. J. Biol. Chem. 281 (2006), 10291–10297.
112. Haces, M.L., Hernández-Fonseca, K., Medina-Campos, O.N., Montiel, T., Pedraza-Chaverri, J., Massieu, L., Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions. Exp. Neurol. 211 (2008), 85–96.
113. Halestrap, A.P., The monocarboxylate transporter family—structure and functional characterization. IUBMB Life 64 (2012), 1–9.
114. Halestrap, A.P., Wilson, M.C., The monocarboxylate transporter family—role and regulation. IUBMB Life 64 (2012), 109–119.
115. Harrison, H.C., Long, C.N.H., The Dros. inf. serv.tribution of ketone bodies in tissues. J. Biol. Chem. 133 (1940), 209–218.
116. Hasegawa, S., Ikeda, Y., Yamasaki, M., Fukui, T., The role of acetoacetyl-CoA synthetase, a ketone body-utilizing enzyme, in 3T3-L1 adipocyte differentiation. Biol. Pharm. Bull. 35 (2012), 1980–1985.
117. Hasegawa, S., Kume, H., Iinuma, S., Yamasaki, M., Takahashi, N., Fukui, T., Acetoacetyl-CoA synthetase is essential for normal neuronal development. Biochem. Biophys. Res. Commun. 427 (2012), 398–403.
118. Hasegawa, S., Noda, K., Maeda, A., Matsuoka, M., Yamasaki, M., Fukui, T., Acetoacetyl-CoA synthetase, a ketone body-utilizing enzyme, is controlled by SREBP-2 and affects serum cholesterol levels. Mol. Genet. Metab. 107 (2012), 553–560.
119. Hasselbaink, D.M., Glatz, J.F., Luiken, J.J., Roemen, T.H., Van der Vusse, G.J., Ketone bodies disturb fatty acid handling in isolated cardiomyocytes derived from control and diabetic rats. Biochem. J. 371 (2003), 753–760.
120. Hebert, A.S., Dittenhafer-Reed, K.E., Yu, W., Bailey, D.J., Selen, E.S., Boersma, M.D., Carson, J.J., Tonelli, M., Balloon, A.J., Higbee, A.J., et al. Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol. Cell 49 (2013), 186–199.
121. Hegardt, F.G., Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis. Biochem. J. 338 (1999), 569–582.
122. Hems, D.A., Brosnan, J.T., Effects of ischaemia on content of metabolites in rat liver and kidney in vivo. Biochem. J. 120 (1970), 105–111.
123. Hersh, L.B., Jencks, W.P., Coenzyme A transferase: kinetics and exchange reactions. J. Biol. Chem. 242 (1967), 3468–3480.
124. Honda, Y., Imajo, K., Kato, T., Kessoku, T., Ogawa, Y., Tomeno, W., Kato, S., Mawatari, H., Fujita, K., Yoneda, M., et al. The selective SGLT2 inhibitor ipragliflozin has a therapeutic effect on nonalcoholic steatohepatitis in mice. PLoS ONE, 11, 2016, e0146337.
125. Hsu, W.Y., Kuo, C.Y., Fukushima, T., Imai, K., Chen, C.M., Lin, P.Y., Lee, J.A., Enantioselective determination of 3-hydroxybutyrate in the tissues of normal and streptozotocin-induced diabetic rats of different ages. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879 (2011), 3331–3336.
126. Huang, D., Li, T., Wang, L., Zhang, L., Yan, R., Li, K., Xing, S., Wu, G., Hu, L., Jia, W., et al. Hepatocellular carcinoma redirects to ketolysis for progression under nutrition deprivation stress. Cell Res. 26 (2016), 1112–1130.
127. Hugo, S.E., Cruz-Garcia, L., Karanth, S., Anderson, R.M., Stainier, D.Y.R., Schlegel, A., A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting. Genes Dev. 26 (2012), 282–293.
128. Huynh, K., Heart failure: ketone bodies as fuel in heart failure. Nat. Rev. Cardiol. 13 (2016), 122–123.
129. Hyötyläinen, T., Jerby, L., Petäjä, E.M., Mattila, I., Jäntti, S., Auvinen, P., Gastaldelli, A., Yki-Järvinen, H., Ruppin, E., Orešič, M., Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease. Nat. Commun., 7, 2016, 8994.
130. Inagaki, N., Goda, M., Yokota, S., Maruyama, N., Iijima, H., Safety and efficacy of canagliflozin in Japanese patients with type 2 diabetes mellitus: post hoc subgroup analyses according to body mass index in a 52-week open-label study. Expert Opin. Pharmacother. 16 (2015), 1577–1591.
131. Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 5 (2007), 415–425.
132. Iozzo, P., Bucci, M., Roivainen, A., Någren, K., Järvisalo, M.J., Kiss, J., Guiducci, L., Fielding, B., Naum, A.G., Borra, R., et al. Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals. Gastroenterology 139 (2010), 846–856 856.e1–856.e6.
133. Ito, M., Fukui, T., Kamokari, M., Saito, T., Tomita, K., Purification and characterization of acetoacetyl-CoA synthetase from rat liver. Biochim. Biophys. Acta 794 (1984), 183–193.
134. Jain, S.K., Kannan, K., Lim, G., Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Radic. Biol. Med. 25 (1998), 1083–1088.
135. Jain, S.K., Kannan, K., Lim, G., McVie, R., Bocchini, J.A. Jr., Hyperketonemia increases tumor necrosis factor-alpha secretion in cultured U937 monocytes and type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency. Diabetes 51 (2002), 2287–2293.
136. Janardhan, A., Chen, J., Crawford, P.A., Altered systemic ketone body metabolism in advanced heart failure. Tex. Heart Inst. J. 38 (2011), 533–538.
137. Jaworski, D.M., Namboodiri, A.M.A., Moffett, J.R., Acetate as a metabolic and epigenetic modifier of cancer therapy. J. Cell. Biochem. 117 (2016), 574–588.
138. Jeffrey, F.M., Diczku, V., Sherry, A.D., Malloy, C.R., Substrate selection in the isolated working rat heart: effects of reperfusion, afterload, and concentration. Basic Res. Cardiol. 90 (1995), 388–396.
139. Jeoung, N.H., Rahimi, Y., Wu, P., Lee, W.N., Harris, R.A., Fasting induces ketoacidosis and hypothermia in PDHK2/PDHK4-double-knockout mice. Biochem. J. 443 (2012), 829–839.
140. Johnson, R.H., Walton, J.L., The effect of exercise upon acetoacetate metabolism in athletes and non-athletes. Q. J. Exp. Physiol. Cogn. Med. Sci. 57 (1972), 73–79.
141. Johnson, R.H., Walton, J.L., Krebs, H.A., Williamson, D.H., Metabolic fuels during and after severe exercise in athletes and non-athletes. Lancet 2 (1969), 452–455.
142. Johnson, R.H., Walton, J.L., Krebs, H.A., Williamson, D.H., Post-exercise ketosis. Lancet 2 (1969), 1383–1385.
143. Jornayvaz, F.R., Jurczak, M.J., Lee, H.Y., Birkenfeld, A.L., Frederick, D.W., Zhang, D., Zhang, X.M., Samuel, V.T., Shulman, G.I., A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain. Am. J. Physiol. Endocrinol. Metab. 299 (2010), E808–E815.
144. Kahn, B.B., Alquier, T., Carling, D., Hardie, D.G., AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1 (2005), 15–25.
145. Kang, H.B., Fan, J., Lin, R., Elf, S., Ji, Q., Zhao, L., Jin, L., Seo, J.H., Shan, C., Arbiser, J.L., et al. Metabolic rewiring by oncogenic BRAF V600E links ketogenesis pathway to BRAF-MEK1 signaling. Mol. Cell 59 (2015), 345–358.
146. Kani, A.H., Alavian, S.M., Esmaillzadeh, A., Adibi, P., Azadbakht, L., Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: a parallel randomized trial. Nutrition 30 (2014), 814–821.
147. Kanikarla-Marie, P., Jain, S.K., Hyperketonemia (acetoacetate) upregulates NADPH oxidase 4 and elevates oxidative stress, ICAM-1, and monocyte adhesivity in endothelial cells. Cell. Physiol. Biochem. 35 (2015), 364–373.
148. Kanikarla-Marie, P., Jain, S.K., 1,25(OH)2D3 inhibits oxidative stress and monocyte adhesion by mediating the upregulation of GCLC and GSH in endothelial cells treated with acetoacetate (ketosis). J. Steroid Biochem. Mol. Biol. 159 (2016), 94–101.
149. Kashiwaya, Y., Pawlosky, R., Markis, W., King, M.T., Bergman, C., Srivastava, S., Murray, A., Clarke, K., Veech, R.L., A ketone ester diet increases brain malonyl-CoA and Uncoupling proteins 4 and 5 while decreasing food intake in the normal Wistar rat. J. Biol. Chem. 285 (2010), 25950–25956.
150. Kassovska-Bratinova, S., Fukao, T., Song, X.Q., Duncan, A.M., Chen, H.S., Robert, M.F., Pérez-Cerdá, C., Ugarte, M., Chartrand, C., Vobecky, S., et al. Succinyl CoA: 3-oxoacid CoA transferase (SCOT): human cDNA cloning, human chromosomal mapping to 5p13, and mutation detection in a SCOT-deficient patient. Am. J. Hum. Genet. 59 (1996), 519–528.
151. Katz, P.M., Leiter, L.A., The role of the kidney and SGLT2 inhibitors in type 2 diabetes. Can. J. Diabetes 39:Suppl 5 (2015), S167–S175.
152. Keller, U., Cherrington, A.D., Liljenquist, J.E., Ketone body turnover and net hepatic ketone production in fasted and diabetic dogs. Am. J. Physiol. 235 (1978), E238–E247.
153. Kemper, M.F., Srivastava, S., Todd King, M., Clarke, K., Veech, R.L., Pawlosky, R.J., An ester of β-hydroxybutyrate regulates cholesterol biosynthesis in rats and a cholesterol biomarker in humans. Lipids 50 (2015), 1185–1193.
154. Kennedy, A.R., Pissios, P., Otu, H., Roberson, R., Xue, B., Asakura, K., Furukawa, N., Marino, F.E., Liu, F.F., Kahn, B.B., et al. A high-fat, ketogenic diet induces a unique metabolic state in mice. Am. J. Physiol. Endocrinol. Metab. 292 (2007), E1724–E1739.
155. Kimura, I., Inoue, D., Maeda, T., Hara, T., Ichimura, A., Miyauchi, S., Kobayashi, M., Hirasawa, A., Tsujimoto, G., Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc. Natl. Acad. Sci. USA 108 (2011), 8030–8035.
156. Klement, R.J., Champ, C.E., Otto, C., Kämmerer, U., Anti-tumor effects of ketogenic diets in mice: a meta-analysis. PLoS ONE, 11, 2016, e0155050.
157. Klocker, A.A., Phelan, H., Twigg, S.M., Craig, M.E., Blood β-hydroxybutyrate vs. urine acetoacetate testing for the prevention and management of ketoacidosis in type 1 diabetes: a systematic review. Diabet. Med. 30 (2013), 818–824.
158. Koeslag, J.H., Noakes, T.D., Sloan, A.W., Post-exercise ketosis. J. Physiol. 301 (1980), 79–90.
159. Koliaki, C., Roden, M., Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease. Mol. Cell. Endocrinol. 379 (2013), 35–42.
160. Koliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W.T., et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab. 21 (2015), 739–746.
161. Kolwicz, S.C. Jr., Airhart, S., Tian, R., Ketones step to the plate: a game changer for metabolic remodeling in heart failure?. Circulation 133 (2016), 689–691.
162. Kossoff, E.H., Hartman, A.L., Ketogenic diets: new advances for metabolism-based therapies. Curr. Opin. Neurol. 25 (2012), 173–178.
163. Kostiuk, M.A., Keller, B.O., Berthiaume, L.G., Palmitoylation of ketogenic enzyme HMGCS2 enhances its interaction with PPARalpha and transcription at the Hmgcs2 PPRE. FASEB J. 24 (2010), 1914–1924.
164. Krebs, H.A., Wallace, P.G., Hems, R., Freedland, R.A., Rates of ketone-body formation in the perfused rat liver. Biochem. J. 112 (1969), 595–600.
165. Krishnakumar, A.M., Sliwa, D., Endrizzi, J.A., Boyd, E.S., Ensign, S.A., Peters, J.W., Getting a handle on the role of coenzyme M in alkene metabolism. Microbiol. Mol. Biol. Rev. 72 (2008), 445–456.
166. Kucejova, B., Duarte, J., Satapati, S., Fu, X., Ilkayeva, O., Newgard, C.B., Brugarolas, J., Burgess, S.C., Hepatic mTORC1 opposes impaired insulin action to control mitochondrial metabolism in obesity. Cell Rep. 16 (2016), 508–519.
167. Kupari, M., Lommi, J., Ventilä, M., Karjalainen, U., Breath acetone in congestive heart failure. Am. J. Cardiol. 76 (1995), 1076–1078.
168. Kurepa, D., Pramanik, A.K., Kakkilaya, V., Caldito, G., Groome, L.J., Bocchini, J.A., Jain, S.K., Elevated acetoacetate and monocyte chemotactic protein-1 levels in cord blood of infants of diabetic mothers. Neonatology 102 (2012), 163–168.
169. Kwiterovich, P.O. Jr., Vining, E.P., Pyzik, P., Skolasky, R. Jr., Freeman, J.M., Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA 290 (2003), 912–920.
170. Laeger, T., Metges, C.C., Kuhla, B., Role of β-hydroxybutyric acid in the central regulation of energy balance. Appetite 54 (2010), 450–455.
171. Lambrechts, D.A.J.E., Brandt-Wouters, E., Verschuure, P., Vles, H.S.H., Majoie, M.J.M., A prospective study on changes in blood levels of cholecystokinin-8 and leptin in patients with refractory epilepsy treated with the ketogenic diet. Epilepsy Res. 127 (2016), 87–92.
172. Lauritzen, K.H., Hasan-Olive, M.M., Regnell, C.E., Kleppa, L., Scheibye-Knudsen, M., Gjedde, A., Klungland, A., Bohr, V.A., Storm-Mathisen, J., Bergersen, L.H., A ketogenic diet accelerates neurodegeneration in mice with induced mitochondrial DNA toxicity in the forebrain. Neurobiol. Aging 48 (2016), 34–47.
173. Le Foll, C., Dunn-Meynell, A.A., Miziorko, H.M., Levin, B.E., Regulation of hypothalamic neuronal sensing and food intake by ketone bodies and fatty acids. Diabetes 63 (2014), 1259–1269.
174. Lehninger, A.L., Sudduth, H.C., Wise, J.B., D-beta-hydroxybutyric dehydrogenase of muitochondria. J. Biol. Chem. 235 (1960), 2450–2455.
175. Lin, G.W., Lu, P., Zeng, T., Tang, H.L., Chen, Y.H., Liu, S.J., Gao, M.M., Zhao, Q.H., Yi, Y.H., Long, Y.S., GAPDH-mediated posttranscriptional regulations of sodium channel Scn1a and Scn3a genes under seizure and ketogenic diet conditions. Neuropharmacology 113 (2017), 480–489.
176. Lin, H.V., Accili, D., Hormonal regulation of hepatic glucose production in health and disease. Cell Metab. 14 (2011), 9–19.
177. Lincoln, B.C., Des Rosiers, C., Brunengraber, H., Metabolism of S-3-hydroxybutyrate in the perfused rat liver. Arch. Biochem. Biophys. 259 (1987), 149–156.
178. Liśkiewicz, A.D., Kasprowska, D., Wojakowska, A., Polański, K., Lewin-Kowalik, J., Kotulska, K., Jędrzejowska-Szypułka, H., Long-term high fat ketogenic diet promotes renal tumor growth in a rat model of tuberous sclerosis. Sci. Rep., 6, 2016, 21807.
179. Lommi, J., Kupari, M., Koskinen, P., Näveri, H., Leinonen, H., Pulkki, K., Härkönen, M., Blood ketone bodies in congestive heart failure. J. Am. Coll. Cardiol. 28 (1996), 665–672.
180. Lommi, J., Koskinen, P., Näveri, H., Härkönen, M., Kupari, M., Heart failure ketosis. J. Intern. Med. 242 (1997), 231–238.
181. Longo, N., Fukao, T., Singh, R., Pasquali, M., Barrios, R.G., Kondo, N., Gibson, K.M., Succinyl-CoA:3-ketoacid transferase (SCOT) deficiency in a new patient homozygous for an R217X mutation. J. Inherit. Metab. Dis. 27 (2004), 691–692.
182. Lopaschuk, G.D., Verma, S., Empagliflozin's fuel hypothesis: not so soon. Cell Metab. 24 (2016), 200–202.
183. Lopaschuk, G.D., Ussher, J.R., Folmes, C.D., Jaswal, J.S., Stanley, W.C., Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 90 (2010), 207–258.
184. Lowe, D.M., Tubbs, P.K., 3-Hydroxy-3-methylglutaryl-coenzyme A synthase from ox liver. Purification, molecular and catalytic properties. Biochem. J. 227 (1985), 591–599.
185. Lukasova, M., Malaval, C., Gille, A., Kero, J., Offermanns, S., Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. J. Clin. Invest. 121 (2011), 1163–1173.
186. Lutas, A., Yellen, G., The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci. 36 (2013), 32–40.
187. Maalouf, M., Rho, J.M., Oxidative impairment of hippocampal long-term potentiation involves activation of protein phosphatase 2A and is prevented by ketone bodies. J. Neurosci. Res. 86 (2008), 3322–3330.
188. Maalouf, M., Sullivan, P.G., Davis, L., Kim, D.Y., Rho, J.M., Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 145 (2007), 256–264.
189. Magnusson, I., Schumann, W.C., Bartsch, G.E., Chandramouli, V., Kumaran, K., Wahren, J., Landau, B.R., Noninvasive tracing of Krebs cycle metabolism in liver. J. Biol. Chem. 266 (1991), 6975–6984.
190. Manji, H.K., Potter, W.Z., Lenox, R.H., Signal transduction pathways. Molecular targets for lithium's actions. Arch. Gen. Psychiatry 52 (1995), 531–543.
191. Männistö, V.T., Simonen, M., Hyysalo, J., Soininen, P., Kangas, A.J., Kaminska, D., Matte, A.K., Venesmaa, S., Käkelä, P., Kärjä, V., et al. Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans. Liver Int. 35 (2015), 1853–1861.
192. Marcondes, S., Turko, I.V., Murad, F., Nitration of succinyl-CoA:3-oxoacid CoA-transferase in rats after endotoxin administration. Proc. Natl. Acad. Sci. USA 98 (2001), 7146–7151.
193. Marinou, K., Adiels, M., Hodson, L., Frayn, K.N., Karpe, F., Fielding, B.A., Young women partition fatty acids towards ketone body production rather than VLDL-TAG synthesis, compared with young men. Br. J. Nutr. 105 (2011), 857–865.
194. Marosi, K., Kim, S.W., Moehl, K., Scheibye-Knudsen, M., Cheng, A., Cutler, R., Camandola, S., Mattson, M.P., 3-Hydroxybutyrate regulates energy metabolism and induces BDNF expression in cerebral cortical neurons. J. Neurochem. 139 (2016), 769–781.
195. Martin, K., Jackson, C.F., Levy, R.G., Cooper, P.N., Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst. Rev., 2, 2016, CD001903.
196. Martinez-Outschoorn, U.E., Lin, Z., Whitaker-Menezes, D., Howell, A., Sotgia, F., Lisanti, M.P., Ketone body utilization drives tumor growth and metastasis. Cell Cycle 11 (2012), 3964–3971.
197. Mascaró, C., Buesa, C., Ortiz, J.A., Haro, D., Hegardt, F.G., Molecular cloning and tissue expression of human mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase. Arch. Biochem. Biophys. 317 (1995), 385–390.
198. Mashimo, T., Pichumani, K., Vemireddy, V., Hatanpaa, K.J., Singh, D.K., Sirasanagandla, S., Nannepaga, S., Piccirillo, S.G., Kovacs, Z., Foong, C., et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell 159 (2014), 1603–1614.
199. Masuoka, H.C., Chalasani, N., Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann. N Y Acad. Sci. 1281 (2013), 106–122.
200. McDonnell, E., Crown, S.B., Fox, D.B., Kitir, B., Ilkayeva, O.R., Olsen, C.A., Grimsrud, P.A., Hirschey, M.D., Lipids reprogram metabolism to become a major carbon source for histone acetylation. Cell Rep. 17 (2016), 1463–1472.
201. McGarry, J.D., Foster, D.W., Hormonal control of ketogenesis. Biochemical considerations. Arch Intern Med. 137 (1977), 495–501.
202. McGarry, J.D., Foster, D.W., Regulation of hepatic fatty acid oxidation and ketone body production. Annu. Rev. Biochem. 49 (1980), 395–420.
203. McNally, M.A., Hartman, A.L., Ketone bodies in epilepsy. J. Neurochem. 121 (2012), 28–35.
204. Meertens, L.M., Miyata, K.S., Cechetto, J.D., Rachubinski, R.A., Capone, J.P., A mitochondrial ketogenic enzyme regulates its gene expression by association with the nuclear hormone receptor PPARalpha. EMBO J. 17 (1998), 6972–6978.
205. Meidenbauer, J.J., Mukherjee, P., Seyfried, T.N., The glucose ketone index calculator: a simple tool to monitor therapeutic efficacy for metabolic management of brain cancer. Nutr. Metab. (Lond.), 12, 2015, 12.
206. Menzies, K.J., Zhang, H., Katsyuba, E., Auwerx, J., Protein acetylation in metabolism—metabolites and cofactors. Nat. Rev. Endocrinol. 12 (2016), 43–60.
207. Merritt, M.E., Harrison, C., Sherry, A.D., Malloy, C.R., Burgess, S.C., Flux through hepatic pyruvate carboxylase and phosphoenolpyruvate carboxykinase detected by hyperpolarized 13C magnetic resonance. Proc. Natl. Acad. Sci. USA 108 (2011), 19084–19089.
208. Morris, A.A., Cerebral ketone body metabolism. J. Inherit. Metab. Dis. 28 (2005), 109–121.
209. Moussaieff, A., Rouleau, M., Kitsberg, D., Cohen, M., Levy, G., Barasch, D., Nemirovski, A., Shen-Orr, S., Laevsky, I., Amit, M., et al. Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells. Cell Metab. 21 (2015), 392–402.
210. Mudaliar, S., Polidori, D., Zambrowicz, B., Henry, R.R., Sodium-glucose cotransporter inhibitors: effects on renal and intestinal glucose transport: from bench to bedside. Diabetes Care 38 (2015), 2344–2353.
211. Mudaliar, S., Alloju, S., Henry, R.R., Can a shift in fuel energetics explain the beneficial cardiorenal outcomes in the EMPA-REG OUTCOME study? A unifying hypothesis. Diabetes Care 39 (2016), 1115–1122.
212. Murphy, M.P., How mitochondria produce reactive oxygen species. Biochem. J. 417 (2009), 1–13.
213. Murray, A.J., Knight, N.S., Cole, M.A., Cochlin, L.E., Carter, E., Tchabanenko, K., Pichulik, T., Gulston, M.K., Atherton, H.J., Schroeder, M.A., et al. Novel ketone diet enhances physical and cognitive performance. FASEB J. 30 (2016), 4021–4032.
214. Nagao, M., Toh, R., Irino, Y., Mori, T., Nakajima, H., Hara, T., Honjo, T., Satomi-Kobayashi, S., Shinke, T., Tanaka, H., et al. β-Hydroxybutyrate elevation as a compensatory response against oxidative stress in cardiomyocytes. Biochem. Biophys. Res. Commun. 475 (2016), 322–328.
215. Neely, J.R., Rovetto, M.J., Oram, J.F., Myocardial utilization of carbohydrate and lipids. Prog. Cardiovasc. Dis. 15 (1972), 289–329.
216. Nei, M., Ngo, L., Sirven, J.I., Sperling, M.R., Ketogenic diet in adolescents and adults with epilepsy. Seizure 23 (2014), 439–442.
217. Neubauer, S., The failing heart—an engine out of fuel. N. Engl. J. Med. 356 (2007), 1140–1151.
218. Newgard, C.B., Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 15 (2012), 606–614.
219. Newman, J.C., Verdin, E., Ketone bodies as signaling metabolites. Trends Endocrinol. Metab. 25 (2014), 42–52.
220. Newsholme, P., Curi, R., Gordon, S., Newsholme, E.A., Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages. Biochem. J. 239 (1986), 121–125.
221. Newsholme, P., Gordon, S., Newsholme, E.A., Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem. J. 242 (1987), 631–636.
222. Niezen-Koning, K.E., Wanders, R.J., Ruiter, J.P., Ijlst, L., Visser, G., Reitsma-Bierens, W.C., Heymans, H.S., Reijngoud, D.J., Smit, G.P., Succinyl-CoA:acetoacetate transferase deficiency: identification of a new patient with a neonatal onset and review of the literature. Eur. J. Pediatr. 156 (1997), 870–873.
223. Nonaka, Y., Takagi, T., Inai, M., Nishimura, S., Urashima, S., Honda, K., Aoyama, T., Terada, S., Lauric acid stimulates ketone body production in the KT-5 astrocyte cell line. J. Oleo Sci. 65 (2016), 693–699.
224. Ohgami, M., Takahashi, N., Yamasaki, M., Fukui, T., Expression of acetoacetyl-CoA synthetase, a novel cytosolic ketone body-utilizing enzyme, in human brain. Biochem. Pharmacol. 65 (2003), 989–994.
225. Okuda, Y., Kawai, K., Ohmori, H., Yamashita, K., Ketone body utilization and its metabolic effect in resting muscles of normal and streptozotocin-diabetic rats. Endocrinol. Jpn. 38 (1991), 245–251.
226. Orii, K.E., Fukao, T., Song, X.Q., Mitchell, G.A., Kondo, N., Liver-specific silencing of the human gene encoding succinyl-CoA: 3-ketoacid CoA transferase. Tohoku J. Exp. Med. 215 (2008), 227–236.
227. Overmyer, K.A., Evans, C.R., Qi, N.R., Minogue, C.E., Carson, J.J., Chermside-Scabbo, C.J., Koch, L.G., Britton, S.L., Pagliarini, D.J., Coon, J.J., Burant, C.F., Maximal oxidative capacity during exercise is associated with skeletal muscle fuel selection and dynamic changes in mitochondrial protein acetylation. Cell Metab. 21 (2015), 468–478.
228. Owen, O.E., Morgan, A.P., Kemp, H.G., Sullivan, J.M., Herrera, M.G., Cahill, G.F. Jr., Brain metabolism during fasting. J. Clin. Invest. 46 (1967), 1589–1595.
229. Owen, O.E., Kalhan, S.C., Hanson, R.W., The key role of anaplerosis and cataplerosis for citric acid cycle function. J. Biol. Chem. 277 (2002), 30409–30412.
230. Pavlova, N.N., Thompson, C.B., The emerging hallmarks of cancer metabolism. Cell Metab. 23 (2016), 27–47.
231. Pawlak, M., Baugé, E., Lalloyer, F., Lefebvre, P., Staels, B., Ketone body therapy protects from lipotoxicity and acute liver failure upon Pparα deficiency. Mol. Endocrinol. 29 (2015), 1134–1143.
232. Pedersen, K.J., The ketonic decomposition of beta-keto carboxylic acids. J. Am. Chem. Soc. 51 (1929), 2098–2107.
233. Pelletier, A., Tardif, A., Gingras, M.H., Chiasson, J.L., Coderre, L., Chronic exposure to ketone bodies impairs glucose uptake in adult cardiomyocytes in response to insulin but not vanadate: the role of PI3-K. Mol. Cell. Biochem. 296 (2007), 97–108.
234. Perry, R.J., Borders, C.B., Cline, G.W., Zhang, X.M., Alves, T.C., Petersen, K.F., Rothman, D.L., Kibbey, R.G., Shulman, G.I., Propionate increases hepatic pyruvate cycling and anaplerosis and alters mitochondrial metabolism. J. Biol. Chem. 291 (2016), 12161–12170.
235. Pietrocola, F., Galluzzi, L., Bravo-San Pedro, J.M., Madeo, F., Kroemer, G., Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab. 21 (2015), 805–821.
236. Pissios, P., Hong, S., Kennedy, A.R., Prasad, D., Liu, F.F., Maratos-Flier, E., Methionine and choline regulate the metabolic phenotype of a ketogenic diet. Mol. Metab. 2 (2013), 306–313.
237. Pitt, J.J., Peters, H., Boneh, A., Yaplito-Lee, J., Wieser, S., Hinderhofer, K., Johnson, D., Zschocke, J., Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency: urinary organic acid profiles and expanded spectrum of mutations. J. Inherit. Metab. Dis. 38 (2015), 459–466.
238. Poff, A.M., Ari, C., Arnold, P., Seyfried, T.N., D'Agostino, D.P., Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer. Int. J. Cancer 135 (2014), 1711–1720.
239. Pougovkina, O., te Brinke, H., Ofman, R., van Cruchten, A.G., Kulik, W., Wanders, R.J.A., Houten, S.M., de Boer, V.C.J., Mitochondrial protein acetylation is driven by acetyl-CoA from fatty acid oxidation. Hum. Mol. Genet. 23 (2014), 3513–3522.
240. Pramfalk, C., Pavlides, M., Banerjee, R., McNeil, C.A., Neubauer, S., Karpe, F., Hodson, L., Sex-specific differences in hepatic fat oxidation and synthesis may explain the higher propensity for NAFLD in men. J. Clin. Endocrinol. Metab. 100 (2015), 4425–4433.
241. Quant, P.A., Tubbs, P.K., Brand, M.D., Glucagon activates mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in vivo by decreasing the extent of succinylation of the enzyme. Eur. J. Biochem. 187 (1990), 169–174.
242. Rahman, M., Muhammad, S., Khan, M.A., Chen, H., Ridder, D.A., Müller-Fielitz, H., Pokorná, B., Vollbrandt, T., Stölting, I., Nadrowitz, R., et al. The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat. Commun., 5, 2014, 3944.
243. Rando, G., Tan, C.K., Khaled, N., Montagner, A., Leuenberger, N., Bertrand-Michel, J., Paramalingam, E., Guillou, H., Wahli, W., Glucocorticoid receptor-PPARα axis in fetal mouse liver prepares neonates for milk lipid catabolism. eLife, 5, 2016, e11853.
244. Rardin, M.J., He, W., Nishida, Y., Newman, J.C., Carrico, C., Danielson, S.R., Guo, A., Gut, P., Sahu, A.K., Li, B., et al. SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab. 18 (2013), 920–933.
245. Rawat, A.K., Menahan, L.A., Antiketogenic action of fructose, glyceraldehyde, and sorbitol in the rat in vivo. Diabetes 24 (1975), 926–932.
246. Raz, I., Cahn, A., Heart failure: SGLT2 inhibitors and heart failure—clinical implications. Nat. Rev. Cardiol. 13 (2016), 185–186.
247. Rebrin, I., Brégère, C., Kamzalov, S., Gallaher, T.K., Sohal, R.S., Nitration of tryptophan 372 in succinyl-CoA:3-ketoacid CoA transferase during aging in rat heart mitochondria. Biochemistry 46 (2007), 10130–10144.
248. Rector, R.S., Thyfault, J.P., Uptergrove, G.M., Morris, E.M., Naples, S.P., Borengasser, S.J., Mikus, C.R., Laye, M.J., Laughlin, M.H., Booth, F.W., Ibdah, J.A., Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J. Hepatol. 52 (2010), 727–736.
249. Reed, W.D., Ozand, P.T., Enzymes of L-(+)-3-hydroxybutyrate metabolism in the rat. Arch. Biochem. Biophys. 205 (1980), 94–103.
250. Reed, W.D., Clinkenbeard, D., Lane, M.D., Molecular and catalytic properties of mitochondrial (ketogenic) 3-hydroxy-3-methylglutaryl coenzyme A synthase of liver. J. Biol. Chem. 250 (1975), 3117–3123.
251. Reichard, G.A. Jr., Owen, O.E., Haff, A.C., Paul, P., Bortz, W.M., Ketone-body production and oxidation in fasting obese humans. J. Clin. Invest. 53 (1974), 508–515.
252. Rho, J.M., How does the ketogenic diet induce anti-seizure effects?. Neurosci. Lett. 637 (2017), 4–10.
253. Rinella, M.E., Sanyal, A.J., Management of NAFLD: a stage-based approach. Nat. Rev. Gastroenterol. Hepatol. 13 (2016), 196–205.
254. Robinson, A.M., Williamson, D.H., Utlization of D-3-hydroxy[3-14C]butyrate for lipogenesis in vivo in lactating rat mammary gland. Biochem. J. 176 (1978), 635–638.
255. Robinson, A.M., Williamson, D.H., Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol. Rev. 60 (1980), 143–187.
256. Rodríguez, J.C., Gil-Gómez, G., Hegardt, F.G., Haro, D., Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J. Biol. Chem. 269 (1994), 18767–18772.
257. Rogawski, M.A., Löscher, W., Rho, J.M., Mechanisms of action of antiseizure drugs and the ketogenic diet. Cold Spring Harb. Perspect. Med., 6, 2016, a022780.
258. Rojas-Morales, P., Tapia, E., Pedraza-Chaverri, J., β-Hydroxybutyrate: a signaling metabolite in starvation response?. Cell. Signal. 28 (2016), 917–923.
259. Rudolph, W., Schinz, A., Studies on myocardial blood flow, oxygen consumption, and myocardial metabolism in patients with cardiomyopathy. Recent Adv. Stud. Cardiac Struct. Metab. 2 (1973), 739–749.
260. Safaei, A., Arefi Oskouie, A., Mohebbi, S.R., Rezaei-Tavirani, M., Mahboubi, M., Peyvandi, M., Okhovatian, F., Zamanian-Azodi, M., Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases. Gastroenterol. Hepatol. Bed Bench 9 (2016), 158–173.
261. Saito, A., Yoshimura, K., Miyamoto, Y., Kaneko, K., Chikazu, D., Yamamoto, M., Kamijo, R., Enhanced and suppressed mineralization by acetoacetate and β-hydroxybutyrate in osteoblast cultures. Biochem. Biophys. Res. Commun. 473 (2016), 537–544.
262. Samuel, V.T., Shulman, G.I., Mechanisms for insulin resistance: common threads and missing links. Cell 148 (2012), 852–871.
263. Sandermann, H. Jr., McIntyre, J.O., Fleischer, S., Site-site interaction in the phospholipid activation of D-beta-hydroxybutyrate dehydrogenase. J. Biol. Chem. 261 (1986), 6201–6208.
264. Sanyal, A.J., Campbell-Sargent, C., Mirshahi, F., Rizzo, W.B., Contos, M.J., Sterling, R.K., Luketic, V.A., Shiffman, M.L., Clore, J.N., Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120 (2001), 1183–1192.
265. Satapati, S., He, T., Inagaki, T., Potthoff, M., Merritt, M.E., Esser, V., Mangelsdorf, D.J., Kliewer, S.A., Browning, J.D., Burgess, S.C., Partial resistance to peroxisome proliferator-activated receptor-alpha agonists in ZDF rats is associated with defective hepatic mitochondrial metabolism. Diabetes 57 (2008), 2012–2021.
266. Satapati, S., Sunny, N.E., Kucejova, B., Fu, X., He, T.T., Méndez-Lucas, A., Shelton, J.M., Perales, J.C., Browning, J.D., Burgess, S.C., Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. J. Lipid Res. 53 (2012), 1080–1092.
267. Satapati, S., Kucejova, B., Duarte, J.A., Fletcher, J.A., Reynolds, L., Sunny, N.E., He, T., Nair, L.A., Livingston, K.A., Fu, X., et al. Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. J. Clin. Invest. 125 (2015), 4447–4462.
268. Sato, K., Kashiwaya, Y., Keon, C.A., Tsuchiya, N., King, M.T., Radda, G.K., Chance, B., Clarke, K., Veech, R.L., Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J. 9 (1995), 651–658.
269. Saudubray, J.M., Specola, N., Middleton, B., Lombes, A., Bonnefont, J.P., Jakobs, C., Vassault, A., Charpentier, C., Day, R., Hyperketotic states due to inherited defects of ketolysis. Enzyme 38 (1987), 80–90.
270. Scholl-Bürgi, S., Höller, A., Pichler, K., Michel, M., Haberlandt, E., Karall, D., Ketogenic diets in patients with inherited metabolic disorders. J. Inherit. Metab. Dis. 38 (2015), 765–773.
271. Schugar, R.C., Crawford, P.A., Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease. Curr. Opin. Clin. Nutr. Metab. Care 15 (2012), 374–380.
272. Schugar, R.C., Huang, X., Moll, A.R., Brunt, E.M., Crawford, P.A., Role of choline deficiency in the Fatty liver phenotype of mice fed a low protein, very low carbohydrate ketogenic diet. PLoS ONE, 8, 2013, e74806.
273. Schugar, R.C., Moll, A.R., André d'Avignon, D., Weinheimer, C.J., Kovacs, A., Crawford, P.A., Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling. Mol. Metab. 3 (2014), 754–769.
274. Schwer, B., Eckersdorff, M., Li, Y., Silva, J.C., Fermin, D., Kurtev, M.V., Giallourakis, C., Comb, M.J., Alt, F.W., Lombard, D.B., Calorie restriction alters mitochondrial protein acetylation. Aging Cell 8 (2009), 604–606.
275. Scofield, R.F., Brady, P.S., Schumann, W.C., Kumaran, K., Ohgaku, S., Margolis, J.M., Landau, B.R., On the lack of formation of L-(+)-3-hydroxybutyrate by liver. Arch. Biochem. Biophys. 214 (1982), 268–272.
276. Scrutton, M.C., Utter, M.F., Pyruvate carboxylase. IX. Some properties of the activation by certain acyl derivatives of coenzyme A. J. Biol. Chem. 242 (1967), 1723–1735.
277. Seiler, S.E., Martin, O.J., Noland, R.C., Slentz, D.H., DeBalsi, K.L., Ilkayeva, O.R., An, J., Newgard, C.B., Koves, T.R., Muoio, D.M., Obesity and lipid stress inhibit carnitine acetyltransferase activity. J. Lipid Res. 55 (2014), 635–644.
278. Seiler, S.E., Koves, T.R., Gooding, J.R., Wong, K.E., Stevens, R.D., Ilkayeva, O.R., Wittmann, A.H., DeBalsi, K.L., Davies, M.N., Lindeboom, L., et al. Carnitine acetyltransferase mitigates metabolic inertia and muscle fatigue during exercise. Cell Metab. 22 (2015), 65–76.
279. Sengupta, S., Peterson, T.R., Laplante, M., Oh, S., Sabatini, D.M., mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 468 (2010), 1100–1104.
280. Serviddio, G., Sastre, J., Bellanti, F., Viña, J., Vendemiale, G., Altomare, E., Mitochondrial involvement in non-alcoholic steatohepatitis. Mol. Aspects Med. 29 (2008), 22–35.
281. Serviddio, G., Bellanti, F., Vendemiale, G., Altomare, E., Mitochondrial dysfunction in nonalcoholic steatohepatitis. Expert Rev. Gastroenterol. Hepatol. 5 (2011), 233–244.
282. Seyfried, T.N., Kiebish, M.A., Marsh, J., Shelton, L.M., Huysentruyt, L.C., Mukherjee, P., Metabolic management of brain cancer. Biochim. Biophys. Acta 1807 (2011), 577–594.
283. Shi, X., Li, X., Li, D., Li, Y., Song, Y., Deng, Q., Wang, J., Zhang, Y., Ding, H., Yin, L., et al. β-Hydroxybutyrate activates the NF-κB signaling pathway to promote the expression of pro-inflammatory factors in calf hepatocytes. Cell. Physiol. Biochem. 33 (2014), 920–932.
284. Shi, X., Li, D., Deng, Q., Peng, Z., Zhao, C., Li, X., Wang, Z., Li, X., Liu, G., Acetoacetic acid induces oxidative stress to inhibit the assembly of very low density lipoprotein in bovine hepatocytes. J. Dairy Res. 83 (2016), 442–446.
285. Shimazu, T., Hirschey, M.D., Hua, L., Dittenhafer-Reed, K.E., Schwer, B., Lombard, D.B., Li, Y., Bunkenborg, J., Alt, F.W., Denu, J.M., et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab. 12 (2010), 654–661.
286. Shimazu, T., Hirschey, M.D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C.A., Lim, H., Saunders, L.R., Stevens, R.D., et al. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339 (2013), 211–214.
287. Shivva, V., Cox, P.J., Clarke, K., Veech, R.L., Tucker, I.G., Duffull, S.B., The population pharmacokinetics of D-β-hydroxybutyrate following administration of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate. AAPS J. 18 (2016), 678–688.
288. Shukla, S.K., Gebregiworgis, T., Purohit, V., Chaika, N.V., Gunda, V., Radhakrishnan, P., Mehla, K., Pipinos, I.I., Powers, R., Yu, F., Singh, P.K., Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer Metab., 2, 2014, 18.
289. Sleiman, S.F., Henry, J., Al-Haddad, R., El Hayek, L., Abou Haidar, E., Stringer, T., Ulja, D., Karuppagounder, S.S., Holson, E.B., Ratan, R.R., et al. Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate. eLife, 5, 2016, e15092.
290. Snorek, M., Hodyc, D., Sedivý, V., Durišová, J., Skoumalová, A., Wilhelm, J., Neckář, J., Kolář, F., Herget, J., Short-term fasting reduces the extent of myocardial infarction and incidence of reperfusion arrhythmias in rats. Physiol. Res. 61 (2012), 567–574.
291. Snyderman, S.E., Sansaricq, C., Middleton, B., Succinyl-CoA:3-ketoacid CoA-transferase deficiency. Pediatrics 101 (1998), 709–711.
292. Soeters, M.R., Sauerwein, H.P., Faas, L., Smeenge, M., Duran, M., Wanders, R.J., Ruiter, A.F., Ackermans, M.T., Fliers, E., Houten, S.M., Serlie, M.J., Effects of insulin on ketogenesis following fasting in lean and obese men. Obesity (Silver Spring) 17 (2009), 1326–1331.
293. Solinas, G., Borén, J., Dulloo, A.G., De novo lipogenesis in metabolic homeostasis: more friend than foe?. Mol. Metab. 4 (2015), 367–377.
294. Sonesson, C., Johansson, P.A., Johnsson, E., Gause-Nilsson, I., Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis. Cardiovasc. Diabetol., 15, 2016, 37.
295. Stanley, W.C., Meadows, S.R., Kivilo, K.M., Roth, B.A., Lopaschuk, G.D., Beta-hydroxybutyrate inhibits myocardial fatty acid oxidation in vivo independent of changes in malonyl-CoA content. Am. J. Physiol. Heart Circ. Physiol. 285 (2003), H1626–H1631.
296. Stern, J.R., Coon, M.J., Del Campillo, A., Schneider, M.C., Enzymes of fatty acid metabolism. IV. Preparation and properties of coenzyme A transferase. J. Biol. Chem. 221 (1956), 15–31.
297. Sullivan, L.B., Gui, D.Y., Hosios, A.M., Bush, L.N., Freinkman, E., Vander Heiden, M.G., Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell 162 (2015), 552–563.
298. Sultan, A.M., D-3-hydroxybutyrate metabolism in the perfused rat heart. Mol. Cell. Biochem. 79 (1988), 113–118.
299. Sun, Z., Lazar, M.A., Dissociating fatty liver and diabetes. Trends Endocrinol. Metab. 24 (2013), 4–12.
300. Sunny, N.E., Satapati, S., Fu, X., He, T., Mehdibeigi, R., Spring-Robinson, C., Duarte, J., Potthoff, M.J., Browning, J.D., Burgess, S.C., Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 298 (2010), E1226–E1235.
301. Sunny, N.E., Parks, E.J., Browning, J.D., Burgess, S.C., Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab. 14 (2011), 804–810.
302. Suzuki, J., Shen, W.J., Nelson, B.D., Selwood, S.P., Murphy, G.M. Jr., Kanehara, H., Takahashi, S., Oida, K., Miyamori, I., Kraemer, F.B., Cardiac gene expression profile and lipid accumulation in response to starvation. Am. J. Physiol. Endocrinol. Metab. 283 (2002), E94–E102.
303. Suzuki, M., Takeda, M., Kito, A., Fukazawa, M., Yata, T., Yamamoto, M., Nagata, T., Fukuzawa, T., Yamane, M., Honda, K., et al. Tofogliflozin, a sodium/glucose cotransporter 2 inhibitor, attenuates body weight gain and fat accumulation in diabetic and obese animal models. Nutr. Diabetes, 4, 2014, e125.
304. Taegtmeyer, H., Failing heart and starving brain: ketone bodies to the rescue. Circulation 134 (2016), 265–266.
305. Taegtmeyer, H., Hems, R., Krebs, H.A., Utilization of energy-providing substrates in the isolated working rat heart. Biochem. J. 186 (1980), 701–711.
306. Taegtmeyer, H., McNulty, P., Young, M.E., Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation 105 (2002), 1727–1733.
307. Taggart, A.K.P., Kero, J., Gan, X., Cai, T.Q., Cheng, K., Ippolito, M., Ren, N., Kaplan, R., Wu, K., Wu, T.J., et al. (D)-β-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J. Biol. Chem. 280 (2005), 26649–26652.
308. Takagi, A., Kume, S., Kondo, M., Nakazawa, J., Chin-Kanasaki, M., Araki, H., Araki, S., Koya, D., Haneda, M., Chano, T., et al. Mammalian autophagy is essential for hepatic and renal ketogenesis during starvation. Sci. Rep., 6, 2016, 18944.
309. Takagi, A., Kume, S., Maegawa, H., Uzu, T., Emerging role of mammalian autophagy in ketogenesis to overcome starvation. Autophagy 12 (2016), 709–710.
310. Tardif, A., Julien, N., Pelletier, A., Thibault, G., Srivastava, A.K., Chiasson, J.L., Coderre, L., Chronic exposure to beta-hydroxybutyrate impairs insulin action in primary cultures of adult cardiomyocytes. Am. J. Physiol. Endocrinol. Metab. 281 (2001), E1205–E1212.
311. Targher, G., Byrne, C.D., Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. J. Clin. Endocrinol. Metab. 98 (2013), 483–495.
312. Targher, G., Day, C.P., Bonora, E., Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N. Engl. J. Med. 363 (2010), 1341–1350.
313. Thevenet, J., De Marchi, U., Domingo, J.S., Christinat, N., Bultot, L., Lefebvre, G., Sakamoto, K., Descombes, P., Masoodi, M., Wiederkehr, A., Medium-chain fatty acids inhibit mitochondrial metabolism in astrocytes promoting astrocyte-neuron lactate and ketone body shuttle systems. FASEB J. 30 (2016), 1913–1926.
314. Thomas, L.K., Ittmann, M., Cooper, C., The role of leucine in ketogenesis in starved rats. Biochem. J. 204 (1982), 399–403.
315. Thompson, G.N., Hsu, B.Y., Pitt, J.J., Treacy, E., Stanley, C.A., Fasting hypoketotic coma in a child with deficiency of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase. N. Engl. J. Med. 337 (1997), 1203–1207.
316. Thorrez, L., Laudadio, I., Van Deun, K., Quintens, R., Hendrickx, N., Granvik, M., Lemaire, K., Schraenen, A., Van Lommel, L., Lehnert, S., et al. Tissue-specific disallowance of housekeeping genes: the other face of cell differentiation. Genome Res. 21 (2011), 95–105.
317. Thumelin, S., Forestier, M., Girard, J., Pegorier, J.P., Developmental changes in mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene expression in rat liver, intestine and kidney. Biochem. J. 292 (1993), 493–496.
318. Tieu, K., Perier, C., Caspersen, C., Teismann, P., Wu, D.C., Yan, S.D., Naini, A., Vila, M., Jackson-Lewis, V., Ramasamy, R., Przedborski, S., D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J. Clin. Invest. 112 (2003), 892–901.
319. Tildon, J.T., Cornblath, M., Succinyl-CoA: 3-ketoacid CoA-transferase deficiency. A cause for ketoacidosis in infancy. J. Clin. Invest. 51 (1972), 493–498.
320. Tran, M.T., Zsengeller, Z.K., Berg, A.H., Khankin, E.V., Bhasin, M.K., Kim, W., Clish, C.B., Stillman, I.E., Karumanchi, S.A., Rhee, E.P., Parikh, S.M., PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection. Nature 531 (2016), 528–532.
321. Tunaru, S., Kero, J., Schaub, A., Wufka, C., Blaukat, A., Pfeffer, K., Offermanns, S., PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat. Med. 9 (2003), 352–355.
322. Turko, I.V., Marcondes, S., Murad, F., Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. Am. J. Physiol. Heart Circ. Physiol. 281 (2001), H2289–H2294.
323. Valente-Silva, P., Lemos, C., Köfalvi, A., Cunha, R.A., Jones, J.G., Ketone bodies effectively compete with glucose for neuronal acetyl-CoA generation in rat hippocampal slices. NMR Biomed. 28 (2015), 1111–1116.
324. Vallon, V., Thomson, S.C., Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition. Diabetologia 60 (2017), 215–225.
325. van Hasselt, P.M., Ferdinandusse, S., Monroe, G.R., Ruiter, J.P., Turkenburg, M., Geerlings, M.J., Duran, K., Harakalova, M., van der Zwaag, B., Monavari, A.A., et al. Monocarboxylate transporter 1 deficiency and ketone utilization. N. Engl. J. Med. 371 (2014), 1900–1907.
326. Veech, R.L., The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot. Essent. Fatty Acids 70 (2004), 309–319.
327. Veech, R.L., Ketone esters increase brown fat in mice and overcome insulin resistance in other tissues in the rat. Ann. N Y Acad. Sci. 1302 (2013), 42–48.
328. Vice, E., Privette, J.D., Hickner, R.C., Barakat, H.A., Ketone body metabolism in lean and obese women. Metabolism 54 (2005), 1542–1545.
329. Viggiano, A., Pilla, R., Arnold, P., Monda, M., D'Agostino, D., Coppola, G., Anticonvulsant properties of an oral ketone ester in a pentylenetetrazole-model of seizure. Brain Res. 1618 (2015), 50–54.
330. von Meyenn, F., Porstmann, T., Gasser, E., Selevsek, N., Schmidt, A., Aebersold, R., Stoffel, M., Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism. Cell Metab. 17 (2013), 436–447.
331. Wagner, G.R., Payne, R.M., Widespread and enzyme-independent Nε-acetylation and Nε-succinylation of proteins in the chemical conditions of the mitochondrial matrix. J. Biol. Chem. 288 (2013), 29036–29045.
332. Wang, P., Tate, J.M., Lloyd, S.G., Low carbohydrate diet decreases myocardial insulin signaling and increases susceptibility to myocardial ischemia. Life Sci. 83 (2008), 836–844.
333. Wang, Q., Zhou, Y., Rychahou, P., Fan, T.W., Lane, A.N., Weiss, H.L., Evers, B.M., Ketogenesis contributes to intestinal cell differentiation. Cell Death Differ., 2016, 10.1038/cdd.2016.142.
334. Wang, Y., Peng, F., Tong, W., Sun, H., Xu, N., Liu, S., The nitrated proteome in heart mitochondria of the db/db mouse model: characterization of nitrated tyrosine residues in SCOT. J. Proteome Res. 9 (2010), 4254–4263.
335. Wang, Z., Ying, Z., Bosy-Westphal, A., Zhang, J., Schautz, B., Later, W., Heymsfield, S.B., Müller, M.J., Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure. Am. J. Clin. Nutr. 92 (2010), 1369–1377.
336. Webber, R.J., Edmond, J., Utilization of L(+)-3-hydroxybutyrate, D(−)-3-hydroxybutyrate, acetoacetate, and glucose for respiration and lipid synthesis in the 18-day-old rat. J. Biol. Chem. 252 (1977), 5222–5226.
337. Wei, Y., Rector, R.S., Thyfault, J.P., Ibdah, J.A., Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J. Gastroenterol. 14 (2008), 193–199.
338. Weidemann, M.J., Krebs, H.A., The fuel of respiration of rat kidney cortex. Biochem. J. 112 (1969), 149–166.
339. Weinert, B.T., Iesmantavicius, V., Moustafa, T., Schölz, C., Wagner, S.A., Magnes, C., Zechner, R., Choudhary, C., Acetylation dynamics and stoichiometry in Saccharomyces cerevisiae. Mol. Syst. Biol., 10, 2014, 716.
340. Wellen, K.E., Thompson, C.B., A two-way street: reciprocal regulation of metabolism and signalling. Nat. Rev. Mol. Cell Biol. 13 (2012), 270–276.
341. Wellen, K.E., Hatzivassiliou, G., Sachdeva, U.M., Bui, T.V., Cross, J.R., Thompson, C.B., ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324 (2009), 1076–1080.
342. Wentz, A.E., d'Avignon, D.A., Weber, M.L., Cotter, D.G., Doherty, J.M., Kerns, R., Nagarajan, R., Reddy, N., Sambandam, N., Crawford, P.A., Adaptation of myocardial substrate metabolism to a ketogenic nutrient environment. J. Biol. Chem. 285 (2010), 24447–24456.
343. Wildenhoff, K.E., Johansen, J.P., Karstoft, H., Yde, H., Sorensen, N.S., Diurnal variations in the concentrations of blood acetoacetate and 3-hydroxybutyrate. The ketone body peak around midnight and its relationship to free fatty acids, glycerol, insulin, growth hormone and glucose in serum and plasma. Acta Med. Scand. 195 (1974), 25–28.
344. Williamson, D.H., Lund, P., Krebs, H.A., The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem. J. 103 (1967), 514–527.
345. Williamson, D.H., Veloso, D., Ellington, E.V., Krebs, H.A., Changes in the concentrations of hepatic metabolites on administration of dihydroxyacetone or glycerol to starved rats and their relationship to the control of ketogenesis. Biochem. J. 114 (1969), 575–584.
346. Williamson, D.H., Bates, M.W., Page, M.A., Krebs, H.A., Activities of enzymes involved in acetoacetate utilization in adult mammalian tissues. Biochem. J. 121 (1971), 41–47.
347. Winder, W.W., Baldwin, K.M., Holloszy, J.O., Enzymes involved in ketone utilization in different types of muscle: adaptation to exercise. Eur. J. Biochem. 47 (1974), 461–467.
348. Winder, W.W., Baldwin, K.M., Holloszy, J.O., Exercise-induced increase in the capacity of rat skeletal muscle to oxidize ketones. Can. J. Physiol. Pharmacol. 53 (1975), 86–91.
349. Wolfrum, C., Besser, D., Luca, E., Stoffel, M., Insulin regulates the activity of forkhead transcription factor Hnf-3β/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. Proc. Natl. Acad. Sci. USA 100 (2003), 11624–11629.
350. Wolfrum, C., Asilmaz, E., Luca, E., Friedman, J.M., Stoffel, M., Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432 (2004), 1027–1032.
351. Woolf, E.C., Syed, N., Scheck, A.C., Tumor metabolism, the ketogenic diet and β-hydroxybutyrate: novel approaches to adjuvant brain tumor therapy. Front. Mol. Neurosci., 9, 2016, 122.
352. Wright, C., Simone, N.L., Obesity and tumor growth: inflammation, immunity, and the role of a ketogenic diet. Curr. Opin. Clin. Nutr. Metab. Care 19 (2016), 294–299.
353. Wu, J.H.Y., Foote, C., Blomster, J., Toyama, T., Perkovic, V., Sundström, J., Neal, B., Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 4 (2016), 411–419.
354. Wu, Y.J., Zhang, L.M., Chai, Y.M., Wang, J., Yu, L.F., Li, W.H., Zhou, Y.F., Zhou, S.Z., Six-month efficacy of the ketogenic diet is predicted after 3 months and is unrelated to clinical variables. Epilepsy Behav. 55 (2016), 165–169.
355. Xie, Z., Zhang, D., Chung, D., Tang, Z., Huang, H., Dai, L., Qi, S., Li, J., Colak, G., Chen, Y., et al. Metabolic regulation of gene expression by histone lysine β-hydroxybutyrylation. Mol. Cell 62 (2016), 194–206.
356. Yamasaki, M., Hasegawa, S., Imai, M., Takahashi, N., Fukui, T., High-fat diet-induced obesity stimulates ketone body utilization in osteoclasts of the mouse bone. Biochem. Biophys. Res. Commun. 473 (2016), 654–661.
357. Yan, J., Young, M.E., Cui, L., Lopaschuk, G.D., Liao, R., Tian, R., Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity. Circulation 119 (2009), 2818–2828.
358. Yang, C., Ko, B., Hensley, C.T., Jiang, L., Wasti, A.T., Kim, J., Sudderth, J., Calvaruso, M.A., Lumata, L., Mitsche, M., et al. Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. Mol. Cell 56 (2014), 414–424.
359. Yang, L., Li, P., Fu, S., Calay, E.S., Hotamisligil, G.S., Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 11 (2010), 467–478.
360. Yang, S.Y., He, X.Y., Schulz, H., Fatty acid oxidation in rat brain is limited by the low activity of 3-ketoacyl-coenzyme A thiolase. J. Biol. Chem. 262 (1987), 13027–13032.
361. Yang, X., Cheng, B., Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity. J. Mol. Neurosci. 42 (2010), 145–153.
362. Yao, J., Chen, S., Mao, Z., Cadenas, E., Brinton, R.D., 2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease. PLoS ONE, 6, 2011, e21788.
363. Yin, J.X., Maalouf, M., Han, P., Zhao, M., Gao, M., Dharshaun, T., Ryan, C., Whitelegge, J., Wu, J., Eisenberg, D., et al. Ketones block amyloid entry and improve cognition in an Alzheimer's model. Neurobiol. Aging 39 (2016), 25–37.
364. Yoshii, Y., Furukawa, T., Saga, T., Fujibayashi, Y., Acetate/acetyl-CoA metabolism associated with cancer fatty acid synthesis: overview and application. Cancer Lett. 356:2 Pt A (2015), 211–216.
365. Youm, Y.H., Nguyen, K.Y., Grant, R.W., Goldberg, E.L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T.D., et al. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21 (2015), 263–269.
366. Young, M.E., McNulty, P., Taegtmeyer, H., Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 105 (2002), 1861–1870.
367. Yum, M.S., Lee, M., Woo, D.C., Kim, D.W., Ko, T.S., Velíšek, L., β-Hydroxybutyrate attenuates NMDA-induced spasms in rats with evidence of neuronal stabilization on MR spectroscopy. Epilepsy Res. 117 (2015), 125–132.
368. Zhang, D., Yang, H., Kong, X., Wang, K., Mao, X., Yan, X., Wang, Y., Liu, S., Zhang, X., Li, J., et al. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 300 (2011), E287–E295.
369. Zhang, W.W., Churchill, S., Lindahl, R., Churchill, P., Regulation of D-β-hydroxybutyrate dehydrogenase in rat hepatoma cell lines. Cancer Res. 49 (1989), 2433–2437.
370. Ziegler, D.R., Ribeiro, L.C., Hagenn, M., Siqueira, I.R., Araújo, E., Torres, I.L., Gottfried, C., Netto, C.A., Gonçalves, C.A., Ketogenic diet increases glutathione peroxidase activity in rat hippocampus. Neurochem. Res. 28 (2003), 1793–1797.
371. Zinman, B., Wanner, C., Lachin, J.M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O.E., Woerle, H.J., et al., EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373 (2015), 2117–2128.
372. Zou, Z., Sasaguri, S., Rajesh, K.G., Suzuki, R., dl-3-Hydroxybutyrate administration prevents myocardial damage after coronary occlusion in rat hearts. Am. J. Physiol. Heart Circ. Physiol. 283 (2002), H1968–H1974.